메뉴 건너뛰기




Volumn 42, Issue 5, 2003, Pages 1103-1104

Reactivity of iron compounds [2]

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; IRON COMPLEX; IRON DEXTRAN; TRANSFERRIN; UNCLASSIFIED DRUG;

EID: 0142250895     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajkd.2003.08.008     Document Type: Article
Times cited : (1)

References (9)
  • 1
    • 0038777439 scopus 로고    scopus 로고
    • Safety in iron management
    • Fishbane S: Safety in iron management. Am J Kidney Dis 41:S18-S26, 2003 (suppl 5)
    • (2003) Am J Kidney Dis , vol.41 , Issue.SUPPL. 5
    • Fishbane, S.1
  • 2
    • 0142234320 scopus 로고
    • The pharmacology of an iron-dextran intramuscular haematinic
    • Martin LE, Bates CM, Beresford CR, et al: The pharmacology of an iron-dextran intramuscular haematinic. Br J Pharmacol 10:375-382, 1955
    • (1955) Br J Pharmacol , vol.10 , pp. 375-382
    • Martin, L.E.1    Bates, C.M.2    Beresford, C.R.3
  • 4
    • 0026679838 scopus 로고
    • Structure/histotoxicity relationship of parenteral iron preparations
    • Geisser P, Baer M, Schaub E: Structure/histotoxicity relationship of parenteral iron preparations. Arzneimittelforschung 42:1439-1452, 1992
    • (1992) Arzneimittelforschung , vol.42 , pp. 1439-1452
    • Geisser, P.1    Baer, M.2    Schaub, E.3
  • 5
    • 4243690381 scopus 로고    scopus 로고
    • IV iron agents donate iron to transferrin in vitro
    • abstr 2152
    • Van Wyck DB, Anderson J, Johnson K: IV iron agents donate iron to transferrin in vitro. J Am Soc Nephrol 12: 417A, 2001 (abstr 2152)
    • (2001) J Am Soc Nephrol , vol.12
    • Van Wyck, D.B.1    Anderson, J.2    Johnson, K.3
  • 6
    • 0038122576 scopus 로고    scopus 로고
    • Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients
    • Esposito BP, Breuer W, Slotki I, Cabantchik ZI: Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients. Eur J Clin Invest 32:42-49, 2002
    • (2002) Eur J Clin Invest , vol.32 , pp. 42-49
    • Esposito, B.P.1    Breuer, W.2    Slotki, I.3    Cabantchik, Z.I.4
  • 8
    • 0029894558 scopus 로고    scopus 로고
    • Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers
    • Danielson BG, Salmonson T, Derendorf H, Geisser P: Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittelforschung 46:615-621, 1996
    • (1996) Arzneimittelforschung , vol.46 , pp. 615-621
    • Danielson, B.G.1    Salmonson, T.2    Derendorf, H.3    Geisser, P.4
  • 9
    • 85112369167 scopus 로고    scopus 로고
    • Reticulo-endothelial mobilization of iron from IV sodium ferric gluconate complexe (Ferrlecit®) is rapid and complete as compared to iron dextran
    • abstr
    • Seligman P, Karhu D, Strobos J: Reticulo-endothelial mobilization of iron from IV sodium ferric gluconate complexe (Ferrlecit®) is rapid and complete as compared to iron dextran. Blood 96:9b, 2000 (abstr)
    • (2000) Blood , vol.96
    • Seligman, P.1    Karhu, D.2    Strobos, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.